- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07647406
Intraseptal and Periodontal Ligament Anaesthesia for Tooth Extraction in Patients With Type 2 Diabetes
Efficacy and Safety of Intraseptal and Periodontal Ligament Anaesthesia for Extraction of Upper Lateral Incisors and Lower First Premolars in Patients With Type 2 Diabetes Mellitus
The goal of this clinical trial is to compare two local anesthesia techniques, intraseptal anesthesia (ISA) and periodontal ligament anesthesia (PLA), in patients with controlled type 2 diabetes mellitus undergoing tooth extraction.
The main questions it aims to answer are:
Which technique provides more effective local anesthesia for tooth extraction? Do ISA and PLA differ in their effects on blood pressure and heart rate during the procedure?
Researchers will compare ISA and PLA to determine which method is more effective and safer in this patient population.
Participants will:
Receive local anesthesia (ISA or PLA) using articaine with epinephrine delivered with a computer-controlled system Undergo extraction of a maxillary lateral incisor or mandibular first premolar Have blood pressure and heart rate measured before, during, and after anesthesia and extraction
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This randomized clinical trial was designed to evaluate and compare the clinical efficacy and safety of intraseptal anesthesia (ISA) and periodontal ligament anesthesia (PLA) in patients with controlled type 2 diabetes mellitus undergoing tooth extraction.
Local anesthetic administration in diabetic patients requires careful consideration due to potential cardiovascular responses and altered tissue sensitivity. Alternative injection techniques such as ISA and PLA may provide effective anesthesia while minimizing systemic effects.
A total of 120 participants were randomly assigned to receive either ISA or PLA. All anesthetic procedures were performed using a computer-controlled local anesthetic delivery system (CCLADS) with 0.6 mL of 4% articaine with 1:100,000 epinephrine (Septanest).
The study included extraction of maxillary lateral incisors and mandibular first premolars. Outcomes included anesthetic success rate, onset time, duration and extent of anesthesia, as well as changes in systolic and diastolic blood pressure, mean arterial pressure, and heart rate measured before, during, and after the procedure.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Vojvodina
-
Pančevo, Vojvodina, Serbien
- Faculty of Dentistry in Pančevo, University of Business Academy in Novi Sad
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Controlled Type 2 diabetes mellitus
- Age 35-77 years
- Patients requiring extraction of maxillary lateral incisors or mandibular first premolars
- Teeth free of acute periodontal disease
- No acute dentoalveolar abscess
- No dental treatment within last 48 hours
- No smoking
- No alcohol or drug dependence
- No contraindications to local anesthetic or vasoconstrictor
Exclusion Criteria:
- Smokers
- Patients with alcohol or drug dependence
- Contraindications to local anesthetics or vasoconstrictors
- Acute periodontal disease at the site of injection
- Acute dentoalveolar abscess
- History of tooth trauma or hypersensitivity in target teeth
- Dental treatment within the last 48 hours prior to procedure
- Non-controlled diabetes mellitus (implied, since study includes controlled DM only
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: ISA (Intraseptal Anaesthesia)
Participants received intraseptal anaesthesia using 0.6 mL of 4% articaine with 1:100,000 epinephrine administered via a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
|
0.6 mL of 4% articaine with 1:100,000 epinephrine administered for intraseptal anaesthesia (ISA) using a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
|
|
Experimental: PLA (Periodontal Ligament Anaesthesia)
Participants received periodontal ligament anaesthesia using 0.6 mL of 4% articaine with 1:100,000 epinephrine administered via a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
|
0.6 mL of 4% articaine with 1:100,000 epinephrine administered for periodontal ligament anaesthesia (PLA) using a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Anesthetic success rate
Zeitfenster: During tooth extraction procedure (5 minutes after administration of local anaesthesia).
|
Anesthetic success rate of intraseptal anaesthesia (ISA) compared with periodontal ligament anaesthesia (PLA) during extraction of maxillary lateral incisors and mandibular first premolars in patients with controlled Type 2 diabetes mellitus.
|
During tooth extraction procedure (5 minutes after administration of local anaesthesia).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Onset time of local anesthesia
Zeitfenster: Immediately after administration of local anesthesia (during procedure)
|
Time from completion of anesthetic injection to the establishment of profound anesthesia in adjacent gingival tissue.
|
Immediately after administration of local anesthesia (during procedure)
|
|
Duration of soft tissue anesthesia
Zeitfenster: During and after procedure (measured at 5-minute intervals until sensation returns)
|
Time period from onset of anesthesia until return of sensation confirmed by pinprick testing in buccal attached gingiva.
|
During and after procedure (measured at 5-minute intervals until sensation returns)
|
|
Width of anesthetic field
Zeitfenster: 10 minutes after successful anesthesia
|
Extent (in millimeters) of anesthetized area in buccal/lingual/palatal attached gingiva and oral mucosa measured using pinprick testing and a flexible ruler.
|
10 minutes after successful anesthesia
|
|
Systolic blood pressure changes
Zeitfenster: Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
|
Changes in systolic blood pressure before, during, and after administration of local anesthesia.
|
Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
|
|
Diastolic blood pressure changes
Zeitfenster: Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
|
Changes in diastolic blood pressure during perioperative period of anesthesia administration.
|
Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
|
|
Mean arterial pressure changes
Zeitfenster: Baseline to 30 minutes post-injection
|
Changes in mean arterial pressure during and after administration of local anesthesia.
|
Baseline to 30 minutes post-injection
|
|
Heart rate changes
Zeitfenster: Baseline, during injection, and 5, 10, 15, 30 minutes after administration
|
Changes in heart rate during and after administration of local anesthesia using ECG monitoring.
|
Baseline, during injection, and 5, 10, 15, 30 minutes after administration
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Vladimir Biocanin, Faculty of Dentistry in Pancevo, Department of Oral Surgery, University of Business Academy in Novi Sad, Serbia
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- No.36/3
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Diabetes mellitus Typ 2
-
Instituto Nacional de Ciencias Medicas y Nutricion...Aktiv, nicht rekrutierend
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... und andere MitarbeiterRekrutierungTyp 2 Diabetes | Diabetes mellitus Typ 2Türkei (türkiye)
-
Endogenex, Inc.Noch keine RekrutierungDiabetes mellitus, Typ 2 | Diabetes | Typ 2 Diabetes mellitus | Typ 2 Diabetes | Typ 2 Diabetes
-
Endogenex, Inc.Noch keine RekrutierungDiabetes mellitus, Typ 2 | Diabetes | Typ 2 Diabetes | Typ-2-Diabetes mellitus (T2DM) | Typ 2 Diabetes
-
SanofiAbgeschlossenDiabetes mellitus Typ 1 – Diabetes mellitus Typ 2Ungarn, Russische Föderation, Deutschland, Polen, Japan, Vereinigte Staaten, Finnland
-
University of North Carolina, Chapel HillAmerican Heart AssociationRekrutierungTyp 2 Diabetes | Ernährung | Diabetes Typ 2 | T2DM (Typ-2-Diabetes mellitus) | Diabetes mellitis | T2DM | Diabetes-AufklärungVereinigte Staaten
-
Indonesia UniversityAbgeschlossen
-
US Department of Veterans AffairsAmerican Diabetes AssociationAbgeschlossenTyp 2 Diabetes mellitusVereinigte Staaten
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Anmeldung auf EinladungTyp 2 Diabetes mellitus | Altern | Hyperglykämie aufgrund von Diabetes mellitus Typ 2Portugal
-
University Hospital Inselspital, BerneAbgeschlossen
Klinische Studien zur Intraseptal anaesthesia (ISA)
-
Eli Lilly and CompanyRekrutierungChronische Rückenschmerzen | Arthrose, Knie | Diabetischer neuropathischer SchmerzVereinigte Staaten, Puerto Rico
-
James P. Rathmell, MDNew York University; National Institute of Neurological Disorders and Stroke... und andere MitarbeiterAbgeschlossenSchmerzhafte diabetische NeuropathieVereinigte Staaten
-
Malaria Vaccine and Drug Development CenterJohns Hopkins UniversityNoch keine RekrutierungPlasmodium Vivax-Infektion | Plasmodium Vivax-Malaria | Malaria -PräventionKolumbien
-
Boston Children's HospitalBeth Israel Deaconess Medical CenterZurückgezogenBronchopulmonale DysplasieVereinigte Staaten
-
ExpreS2ion BiotechnologiesGouya Insights; KKS MedUni Vienna; VelaLabsRekrutierungBrustkrebs | Brustkrebs metastasiertÖsterreich
-
NeovacsZurückgezogenDermatomyositisItalien, Frankreich, Schweiz, Deutschland
-
National Cancer Institute (NCI)BeendetNierenzellkarzinomVereinigte Staaten
-
NeovacsBeendetSystemischer Lupus erythematodesVereinigte Staaten, Deutschland, Italien, Taiwan, Thailand, Mexiko, Argentinien, Belgien, Frankreich, Schweiz, Georgia, Philippinen, Russische Föderation, Korea, Republik von, Kroatien, Peru, Polen, Kolumbien, Chile, Tunesien, Moldawien...
-
National Cancer Institute (NCI)AbgeschlossenWiederkehrender Prostatakrebs | Adenokarzinom der ProstataVereinigte Staaten